Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
暂无分享,去创建一个
W. Strittmatter | Y. Urade | T. Toda | T. Inui | O. Onodera | Y. Nagai | H. A. Popiel | N. Fujikake | J. Burke | Atsushi Ichikawa
[1] W. Braun,et al. Sequence specificity, statistical potentials, and three‐dimensional structure prediction with self‐correcting distance geometry calculations of β‐sheet formation in proteins , 2008 .
[2] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[3] K. Hasegawa,et al. Amyloid Fibril Formation in the Context of Full-length Protein , 2003, Journal of Biological Chemistry.
[4] W. Strittmatter,et al. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. , 2003, Human molecular genetics.
[5] D. Dash,et al. Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach , 2003, Protein science : a publication of the Protein Society.
[6] Junying Yuan,et al. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders , 2003, Nature.
[7] R. Wetzel,et al. Mutational analysis of the structural organization of polyglutamine aggregates , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[9] Ronald Wetzel,et al. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.
[10] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[11] T. Hashikawa,et al. Intra- and Intermolecular β-Pleated Sheet Formation in Glutamine-repeat Inserted Myoglobin as a Model for Polyglutamine Diseases* , 2001, The Journal of Biological Chemistry.
[12] C. Jodice,et al. Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro , 2001, Brain Research Bulletin.
[13] C. Ross,et al. Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. , 2001, Trends in Molecular Medicine.
[14] M. F. Perutz,et al. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.
[15] A. Goldberg,et al. Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.
[16] James F. Gusella,et al. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.
[17] James R. Burke,et al. Inhibition of Polyglutamine Protein Aggregation and Cell Death by Novel Peptides Identified by Phage Display Screening* , 2000, The Journal of Biological Chemistry.
[18] H. Paulson,et al. Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease , 1999, The Journal of Neuroscience.
[19] C. Ross,et al. Preparation of human cDNAs encoding expanded polyglutamine repeats , 1999, Neuroscience Letters.
[20] A. Novelletto,et al. CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[21] Claudio Soto,et al. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.
[22] A. Roses,et al. Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells. , 1997, Biochemical and biophysical research communications.
[23] Hans Lehrach,et al. Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.
[24] C. Soto,et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.
[25] B. Popovich,et al. A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. , 1995, Human molecular genetics.
[26] Y. Agid,et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.
[27] M. Hurle,et al. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. , 1995, Biochemistry.
[28] Ponzy Lu,et al. Prediction of protein structure and principles of protein conformation Edited by G. D. Fasman. New York: Plenum Press. (1989). 798 pp. $95.00 , 1990, Cell.
[29] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[30] J. Richardson,et al. Principles and Patterns of Protein Conformation , 1989 .